Simultaneous estimation of telmisartan and atorvastatin calcium in API and tablet dosage form
A new method has been established for the simultaneous estimation of Telmisartan and Atorvastatin calcium by RP-HPLC method. The chromatographic conditions were successfully developed for the separation of Telmisartan and Atorvastatin calcium by using boston ODS C18 column, flow rate was 1.0ml/min, mobile Phase consists of methanol:Acetonitrile:buffer in ratio of 35:25:40. Detection wave length was 235nm.The instrument used was SHIMADZU HPLC auto sampler. The retention time of Atorvastatin calcium and Telmisartan was found to be 2.350 and 3.490 minutes respectively. The analytical method was validated according to ICH guidelines (ICH Q2b). The correlation coefficient (r2) was found to be 0.997 and 0.999 for Telmisartan and Atorvastatin calcium respectively. % mean recovery was found to be 100.943% and 100.576% for Telmisartan and Atorvastatin calcium respectively. %RSD for precision on replicate injection was 0.46 and 0.70 for Telmisartan and Atorvastatin calcium respectively. The validation study was found to be precise, robust, and repeatable.
Keywords: Telmisartan, Atorvastatin calcium, ICH guidelines, Validation.
2. Pandey A, Sawarkar H, Singh M, Kashyap P, Ghosh P; UV-Spectrophotometric Method forestimation of Telmisartan in Bulk and Tablet Dosage Form; International Journal of ChemTech Research; 2001; 3(2):657-660
3. Zhang G, Ruan S, Guo B, Gao S; Determination of Telmisartan tablets by HPLC; Guide of china medicine; 2008 ; 1.
4. Mustafa G, Azeem A, Ahmad FJ, Khan ZI, Shakeel F, Talegaonkar S; Stability-indicating RP-HPLCmethod for analysis of Atorvastatin in bulk drug, marketed tablet and nanoemulsion formulation; Journal of the Chilean chemical society; 2010; 55(2):184-188
5. Aluntas TG, Erk N; Liquid Chromatographic Determination of Atorvastatin in Bulk Drug, Tablets, and Human Plasma; Journal of liquid chromatography and related technologies; 2004; 27(1).
6. Patil UP, Gandhi SV, Sengar MR, Rajmane VS; simultaneous determination of atorvastatin calcium and Telmisartan in tablet dosage form by spectrophotometry; International Journal of ChemTech Research; 2009; 1(4):970-973
7. Saravanan V., Revathi R., Meera N. method development and validation for the simultaneous estimation of lycopene and ubidecarenone by RP-HPLC in combined pharmaceutical dosage form. Journal of Drug Delivery and Therapeutics, 2016; 6(5):46-51.
8. Kottai Muthu, R. Sankhla, Gupta Sh, Smith AA, Manavalan R; Development and Validation of a Reversed Phase HPLC Method forSimultaneous Determination of Amlodipine and Telmisartan in Pharmaceutical Dosage Form; Journal of applied chemistry and research; 2010; 12:43-52
9. Kurade VP, Pai MG, Gude R; RP-HPLC Estimation of Ramipril and Telmisartan in Tablets; Indian Journal of pharmaceutical sciences; 2009; 71(2):148-151
10. Damle MC, Patole SM, Potale LV, Khodke AS; A validated HPLC method for analysis of Atorvastatin calcium, Ramipril and Aspirin as the bulk drug and in combined capsule dosage form; International Journal of comprehensive pharmacy; 2010; 1(1).
11. Wankhede SB, Tajne MR, Gupta KR, Wadokhar SG; RP-HPLC method for simultaneous estimation of telmisartan and hydrochlorothiazide in tablet dosage form; Indian Journal of pharmaceutical sciences; 2007; 69(2:298-300
12. Mohammadi A, Rezanour N, Dogaheh MA, Bidkorbeh FG, Hashem MR, Walke Br; A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets; Journal of chromatography B; 2007; 846(1):215-221
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).